Recent Finacing
Recent Raise
Eutilex develops anti-tumor adoptive T cell and monoclonal antibody therapeutics, advancing a 4-1BB CTL into Phase 2 and expanding R&D with a GMP manufacturing facility in Seoul.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
